Last updated on January 2020

Evaluate F901318 Treatment of Invasive Fungal Infections in Patients Lacking Treatment Options


Brief description of study

A study to evaluate F901318 (study drug) for the treatment of invasive fungal infections in patients lacking suitable alternative treatment options.

Detailed Study Description

This is the first study in patients of F901318. Patients with a limited treatment options will be enrolled and treated with F901318 (olorofim) for up to 12 weeks.

Clinical Study Identifier: NCT03583164

Find a site near you

Start Over

The Alfred Hospital

Melbourne, Australia
2.34miles
  Connect »

Royal Melbourne Hospital

Melbourne, Australia
3.51miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.